SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-036527
Filing Date
2020-06-15
Accepted
2020-06-15 12:44:24
Documents
1
Period of Report
2020-06-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4085
  Complete submission text file 0001209191-20-036527.txt   5435
Mailing Address 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713
Business Address 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713 919.806.1074
CHIMERIX INC (Issuer) CIK: 0001117480 (see all company filings)

IRS No.: 330903395 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2505 MERIDIAN PARKWAY, C/O CHIMERIX, INC SUITE 100 DURHAM NC 27713
Business Address
Greissing Ed (Reporting) CIK: 0001735359 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35867 | Film No.: 20962618